About This Fund
Columbus Life Sciences Fund IV is a venture capital fund based in Spain and managed by Columbus Venture Partners. The fund has a size of 150 million euros and it is aimed at biotechnology and pharmaceutical startups. The portfolio of companies selected for this fund will focus on disruptive treatments and industrial development, particularly in the drug development process. The fund plans to make between ten and twelve investments in total. Investments from this fund will range from three million euros to a maximum of twenty million euros over the life cycle of the company. The investment timeframe for selecting portfolio companies is up to three years, with a total period of ten years to close. The Columbus VP team, led by founders and managing partners Javier García and Damià Tormo, along with partners Julen Oyarzábal, José Mesa, and Robert Armstrong, will manage this new fund.